SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001551163-16-000347
Filing Date
2016-04-14
Accepted
2016-04-14 10:12:07
Documents
30
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 f10kdec312015vedgar6.htm 10-K 484410
2 f10kdec312015vedgar6002.gif GRAPHIC 858122
3 f10kdec312015vedgar6003.jpg GRAPHIC 37182
5 exhibit311.htm EX-31 7481
6 exhibit321.htm EX-32 4096
  Complete submission text file 0001551163-16-000347.txt   2359259

Data Files

Seq Description Document Type Size
7 prtt-20151231.xml EX-101.INS 115298
8 prtt-20151231.xsd EX-101.SCH 7700
9 prtt-20151231_cal.xml EX-101.CAL 13836
10 prtt-20151231_def.xml EX-101.DEF 12372
11 prtt-20151231_lab.xml EX-101.LAB 65397
12 prtt-20151231_pre.xml EX-101.PRE 49986
Mailing Address 2681 EAST PARLEYS WAY SUITE 204 SALT LAKE CITY UT 84109
Business Address 2681 EAST PARLEYS WAY SUITE 204 SALT LAKE CITY UT 84109 8013223401
PROTECT PHARMACEUTICAL Corp (Filer) CIK: 0001493526 (see all company filings)

IRS No.: 271877179 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-54001 | Film No.: 161570662
SIC: 2834 Pharmaceutical Preparations